Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash from Investing Activities (2024 - 2025)

Carlsmed (CARL) has disclosed Cash from Investing Activities for 2 consecutive years, with -$24.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 39621.31% year-over-year to -$24.2 million, compared with a TTM value of -$24.7 million through Dec 2025, changed N/A, and an annual FY2025 reading of -$25.5 million, down 14057.22% over the prior year.
  • Cash from Investing Activities was -$24.2 million for Q4 2025 at Carlsmed, down from -$343000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$52000.0 in Q3 2024 and bottomed at -$24.2 million in Q4 2025.